Scicon MR 60mg Gliclazide Tablets – Type 2 Diabetes
Scicon MR 60mg is a prescription modified-release tablet containing Gliclazide 60mg for the management of blood sugar levels in adults with type 2 diabetes mellitus. The higher-dose modified-release formulation provides stable glycaemic control throughout the day. A valid prescription from a licensed physician is required.
Pay in 3 Installments of
Rs.
283
Scicon Mr 60mg Gliclazide Tablets – Type 2 Diabetes
Description
Scicon MR 60mg – Gliclazide Modified-Release Tablets for Type 2 Diabetes
This medicine requires a valid prescription from a licensed physician.
Scicon MR 60mg is a prescription modified-release (MR) tablet containing Gliclazide 60mg, manufactured by Scilife. Gliclazide belongs to the sulfonylurea class of oral antidiabetic medicines. It lowers blood glucose by stimulating the pancreas to secrete more insulin, and is used in adults with type 2 diabetes mellitus whose blood sugar is not adequately controlled through diet and lifestyle changes alone.
The 60mg modified-release strength offers a higher therapeutic dose compared to Scicon MR 30mg, indicated when escalation of gliclazide therapy is required under physician guidance. The modified-release formulation provides gradual, controlled drug delivery throughout the day, supporting stable glycaemic control with a reduced risk of hypoglycaemia.
Scicon MR 60mg must be taken exactly as prescribed. Regular monitoring of blood glucose, adherence to a prescribed diet, and maintained physical activity are essential components of effective type 2 diabetes management.
Clinical Information
- Active ingredient: Gliclazide 60mg (modified release)
- Drug class: Sulfonylurea — oral antidiabetic
- Indication: Type 2 diabetes mellitus in adults
- Formulation: Extended-release tablet — swallow whole; do not crush, break, or chew
- Rx: Prescription required from a licensed physician
Important Information
Monitor blood glucose regularly while on gliclazide therapy. Be alert to signs of hypoglycaemia — sweating, trembling, dizziness, confusion, or palpitations — and seek medical attention if these occur. Do not adjust the dose or discontinue without physician consultation.
Explore our Tablets and Capsules or browse our General Medicines collection.
Usage & Benefits
- Lowers blood glucose levels in adults with type 2 diabetes at 60mg strength
- Modified-release formulation provides stable, all-day glycaemic control
- Reduces hypoglycaemia risk compared to immediate-release formulations
- Sulfonylurea mechanism stimulates pancreatic insulin secretion
- Indicated when 30mg gliclazide dose requires escalation under physician supervision
- Supports long-term reduction in diabetes-related complication risk
How To Use
Take Scicon MR 60mg exactly as prescribed by your physician. Swallow the tablet whole with a glass of water — do not crush, break, or chew the modified-release tablet. Typically taken once daily with breakfast. Monitor blood glucose regularly and be alert to signs of hypoglycaemia (low blood sugar). Do not stop or adjust the dose without consulting your doctor.
FAQs
What is Scicon MR 60mg used for?
Scicon MR 60mg contains Gliclazide 60mg and is prescribed for type 2 diabetes mellitus management in adults when lower-dose or other antidiabetic therapy needs optimisation. It requires a valid prescription.
What is the difference between Scicon MR 30mg and Scicon MR 60mg?
Both contain gliclazide in a modified-release formulation. The 60mg strength provides a higher dose for patients whose blood sugar requires additional control — as determined and prescribed by a physician.
Why must I swallow the tablet whole?
Scicon MR is a modified-release formulation. Crushing or chewing releases all the gliclazide at once, bypassing the controlled delivery system and significantly increasing the risk of hypoglycaemia.


